Synthetic foldamer SK-129 shows promise against Parkinson's disease
Researchers led by Sunil Kumar at the University of Denver have created a synthetic molecule called SK-129, a laboratory‑designed foldamer that binds to several regions of the protein alpha‑synuclein. By holding the protein in a shape that is less likely to stick to other copies, SK-129 prevents the formation and spread of toxic protein clumps that are implicated in Parkinson’s disease.
In mouse studies the compound reduced disease‑related symptoms, suggesting a potential new therapeutic avenue not only for Parkinson’s but also for other neurodegenerative disorders such as Alzheimer’s disease and ALS. Foldamers are noted for their ability to engage targets that traditional drugs cannot reach.
The molecule has not yet been tested in humans, and questions remain about its long‑term safety, optimal dosing and how it behaves in the human body. Additional research is required before clinical use can be considered.
Entities
Parkinson's disease · SK-129 · Sunil Kumar · University of Denver · alpha-synuclein
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] SK-129 has not yet been tested in humans, and its long‑term safety and optimal dosing are unknown. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] SK-129 is a foldamer that binds to multiple sites on the protein alpha‑synuclein. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] Researchers at the University of Denver developed a synthetic molecule called SK-129. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] Further studies are needed to assess the safety, dosing and pharmacokinetics of SK-129 before clinical use. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] Foldamers can target proteins that are considered “undruggable” by conventional drugs. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] By binding alpha‑synuclein, SK-129 stabilizes the protein in a shape less prone to aggregation. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] The foldamer approach may be applicable to other neurodegenerative diseases such as Alzheimer’s disease and ALS. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com
- [● 3 SOURCES] In mouse models, SK-129 reduced symptoms associated with Parkinson’s disease. pontevedrarecorder.com · www.hcnews.com · republicmonitor.com